A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cefoxitin
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Suvorexant is combined with Oliceridine.
Cefoxitin
Abametapir
The serum concentration of Suvorexant can be increased when it is combined with Abametapir.
Cefoxitin
Selpercatinib
The serum concentration of Selpercatinib can be increased when it is combined with Suvorexant.
Cefoxitin
Capmatinib
The serum concentration of Capmatinib can be increased when it is combined with Suvorexant.
Cefoxitin
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Suvorexant.
Cefoxitin
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Suvorexant.
Cefoxitin
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Suvorexant.
Cefoxitin
Cenobamate
The serum concentration of Suvorexant can be decreased when it is combined with Cenobamate.
Cefoxitin
Lefamulin
Suvorexant may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Cefoxitin
Acetyldigoxin
Suvorexant may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Cefoxitin
Metildigoxin
Suvorexant may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Cefoxitin
Naphazoline
The risk or severity of CNS depression can be increased when Naphazoline is combined with Suvorexant.
Cefoxitin
Esketamine
The risk or severity of adverse effects can be increased when Suvorexant is combined with Esketamine.
Cefoxitin
Emapalumab
The metabolism of Suvorexant can be increased when combined with Emapalumab.
Cefoxitin
Siltuximab
The metabolism of Suvorexant can be increased when combined with Siltuximab.
Cefoxitin
Secukinumab
The metabolism of Suvorexant can be increased when combined with Secukinumab.
Cefoxitin
Certolizumab pegol
The metabolism of Suvorexant can be increased when combined with Certolizumab pegol.
Cefoxitin
Golimumab
The metabolism of Suvorexant can be increased when combined with Golimumab.
Cefoxitin
Rilonacept
The metabolism of Suvorexant can be increased when combined with Rilonacept.
Cefoxitin
Tocilizumab
The metabolism of Suvorexant can be increased when combined with Tocilizumab.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3